archetype (adl_version=1.4)
	openEHR-EHR-EVALUATION.fuhrman_nuclear_grade_ccrcc_assessment.v1

concept
	[at0000]	-- Fuhrman Nuclear Grade (ccRCC) utvärdering
language
	original_language = <[ISO_639-1::en]>
	translations = <
		["sv"] = <
			language = <[ISO_639-1::sv]>
			author = <
				["name"] = <"Dennis Forslund">
				["email"] = <"models@cambiocds.com">
				["organisation"] = <"Cambio Healthcare Systems">
			>
		>
	>
description
	original_author = <
		["name"] = <"Syeeda S Farruque">
		["email"] = <"models@cambiocds.com">
		["organisation"] = <"Cambio Healthcare Systems">
		["date"] = <"2017-06-25">
	>
	details = <
		["en"] = <
			language = <[ISO_639-1::en]>
			purpose = <"The Fuhrman Nuclear Grade for Clear Cell Renal Cell Carcinoma (ccRCC) tool uses the physical appearance of cells in renal tissue to provide a prognostic assessment of  tumour cells. This provides a pathological grading system specifically for RCC (of the clear cell type) which can be used to independantly predict cancer-specific survival. Higher grades correlates with a worsening prognosis.">
			use = <"To be used with patients who have clear cell Renal Cell Carcinomas (RCC) and where pathological assessments needed to visualise the cells are available.

There are 4 variables that are scored and which contribute to the 4 grades:

Nuclear diameter, Nuclear shape, Nucleoli and Bizzare often multilobed nuclei and/or spindle cells. 

The 5 year survival figures for each grade:

Grade I: 96%
Grade II: 84%
Grade III: 59%
Grade IV: 31%">
			keywords = <"Fuhrman Nuclear Grade", "Clear Cell Renal Cell Carcinoma", "SSIGN", "5 year survivial">
			misuse = <"As there are no validated scoring systems for providing ccRCC survival, this tool and other associated tools (such as the SSIGN) should be used with sound clinical judgment to provide a more rounded prognostic picture.">
			copyright = <"© Cambio Healthcare Systems">
		>
		["sv"] = <
			language = <[ISO_639-1::sv]>
			purpose = <"Att vid klarcellig njurcancer värdera prognos uttryckt i femårsöverlevnad baserat på cellkaraktäristika.">
			use = <"Använd för att vid klarcellig njurcancer värdera prognos uttryckt i femårsöverlevnad baserat på cellkaraktäristika.

Fyra parametrar bedöms och poängsätts enligt skala: 
- Cellkärnans diameter
- Cellkärnans form
- Nukleoler
- Bisarra, ofta multilobulerade cellkärnor 

Gradering enligt Fuhrman (delvis citerad från referens 2):

Grad 1
Cellkärnorna i tumörcellerna är små (< 10 µm), hyperkromatiska och runda (likt mogna lymfocyter), utan synliga nukleoler.

Grad 2
Med x10 förstoring ses större cellkärnor (15 µm) med oregelbunden kontur, samt små nukleoler.

Grad 3
Med x10 förstoring ses större cellkärnor (20 µm), eventuellt med oval form, med klart oregelbunden kontur. Prominenta nukleoler.

Grad 4
Egenskaper som vid grad 3 med tillägg av bisarra ofta multilobulerade cellkärnor som
innehåller stora kromatinaggregat

5-årsöverlevnad baserat på indelning enligt ovan:
Grad I: 96%
Grad II: 84%
Grad III: 59%
Grad IV: 31%">
			keywords = <"njurcancer", "cancer", "Fuhrman", "Fuhrman Nuclear Grade", "onkologi", "5-årsöverlevnad", "femårsöverlevnad", "klarcellig njurcancer">
			misuse = <"Detta instrument är endast avsett att användas som understöd till klinisk bedömning baserad på grundligt utförd utredning.">
			copyright = <"© Cambio Healthcare Systems">
		>
	>
	lifecycle_state = <"AuthorDraft">
	other_contributors = <>
	other_details = <
		["references"] = <"Ref. 1: Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982 Oct;6(7):655-63.

Ref. 2: Cancercentrum. Njurcancer, Nationell Kvalitetsregisterrapport. 2013. Available from:
https://www.cancercentrum.se/globalassets/cancerdiagnoser/urinvagar/njurcancer/kvalitetsregister/njure_kvalregrapp_2014-11-21.pdf">
		["MD5-CAM-1.0.1"] = <"B303AB947487B9F334FC3E9382B7073F">
	>

definition
	EVALUATION[at0000] matches {	-- Fuhrman Nuclear Grade (ccRCC) utvärdering
		data matches {
			ITEM_TREE[at0001] matches {	-- *Tree(en)
				items cardinality matches {0..*; unordered} matches {
					ELEMENT[at0002] occurrences matches {0..1} matches {	-- 5-årsöverlevnad
						value matches {
							1|[local::at0003], 	-- 96%
							2|[local::at0004], 	-- 84%
							3|[local::at0005], 	-- 59%
							4|[local::at0006]  	-- 31%
						}
					}
				}
			}
		}
	}

ontology
	term_definitions = <
		["en"] = <
			items = <
				["at0000"] = <
					text = <"Fuhrman nuclear grade ccrcc assessment">
					description = <"The Fuhrman Nuclear Grade for Clear Cell Renal Cell Carcinoma (ccRCC) tool uses the physical appearance of cells in renal tissue to provide a prognostic tool to assess tumour cells. This model helps to allocate the 5 year survival figures to each of the 4 Grades">
				>
				["at0001"] = <
					text = <"Tree">
					description = <"@ internal @">
				>
				["at0002"] = <
					text = <"5 Year Survival">
					description = <"The 5 year survival figures for each grade">
				>
				["at0003"] = <
					text = <"96%">
					description = <"Grade I">
				>
				["at0004"] = <
					text = <"84%">
					description = <"Grade II">
				>
				["at0005"] = <
					text = <"59%">
					description = <"Grade III">
				>
				["at0006"] = <
					text = <"31%">
					description = <"Grade IV">
				>
			>
		>
		["sv"] = <
			items = <
				["at0000"] = <
					text = <"Fuhrman Nuclear Grade (ccRCC) utvärdering">
					description = <"Fuhrman Nuclear Grade for Clear Cell Renal Cell Carcinoma (ccRCC) är ett instrument för bedömning av prognos vid klarcellig njurcellscancer.">
				>
				["at0001"] = <
					text = <"*Tree(en)">
					description = <"*@ internal @(en)">
				>
				["at0002"] = <
					text = <"5-årsöverlevnad">
					description = <"Femårsöverlevnad baserat på gradering i enlighet med Fuhrman Nuclear Grade.">
				>
				["at0003"] = <
					text = <"96%">
					description = <"Grad I">
				>
				["at0004"] = <
					text = <"84%">
					description = <"Grad II">
				>
				["at0005"] = <
					text = <"59%">
					description = <"Grad III">
				>
				["at0006"] = <
					text = <"31%">
					description = <"Grad IV">
				>
			>
		>
	>
